| Trial Identifier: | D6930R00002 |
| Sponsor: | AstraZeneca |
| Collaborator: | UNIVERSITY OF OXFORD |
| NCTID: | NCT04168216 |
| Start Date: | November 2020 |
| Primary Completion Date: | June 2022 |
| Study Completion Date: | June 2022 |
| Condition: | Chronic Obstructive Pulmonary Disease (COPD) |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
| Country | Location |
|---|---|
| United Kingdom, Oxfordshire | Oxford, Oxfordshire, United Kingdom, OX3 7LE |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2023 Pharma Intelligence UK Limited (Citeline), a Norstella company